A graduate intern working with me stated that in her pharmacy law class, she was informed that the consultation laws in Wisconsin have been changed so that the pharmacist now does not have to hand every Rx (including new Rxs if the patient has been consulted) to the customer. This change was brought on by a recent citation of me, which caused the board to rethink this rule (see Viewpoint, April 14.)
In settling a class action suit, the Centers for Medicare & Medicaid Services has agreed to make changes to the low income subsidy program for Medicare Part D.
Medi-Cal slashed reimbursement for prescription drugs in California by 10%, effective July 1.
CMS issues a final rule specifying how providers can appeal when their Medicare billing privileges are denied or revoked.
A mother and two daughters were sentenced to prison for Medicare fraud.
Florida has passed a law requiring technicians to pass a program accredited by NCCA.
Besides recommended and not recommended Internet pharmacy sites, NABP is adding a third one-reviewed but not accredited.
A proposed rule by the DEA allows e-prescribing of controlled substances as long as standards are met.
A court rules that Mississippi was wrong in issuing a final rule that would have curtailed reimbursement to pharmacists for generic drugs.
The leading pharmacy industry associations applauded the House of Representatives for voting to pass H.R. 6331.
CMS announced that the ombudsmen for the DMEPOS competitive bidding program are available to assist providers.
CPhA has warned pharmacies that their stores must have aisles that are wide enough for wheelchair bound patients to go through or they risk being sued.
A new study has found that Medicare's competitive bidding program could impede seniors' access to diabetes testing supplies.
Pfizer hopes to stave off the genericization of Lipitor by a year via a deal with Ranbaxy.
The National Association of Chain Drug Stores is encouraging Republican Senator Chuck Grassley of Iowa to include a fix for the Medicaid average manufacturer price rule.
The U.S. Senate, following in the footsteps of the House, has introduced a resolution urging FDA to lift its restrictions on the use of estriol in bioidentical hormone preparation.
NACDS supports introduction of House Bill H.R. 6252 to reform DMEPOS competitive bidding.
OIG has released a report on FDA's generic drug review process.
Sen. Henry Waxman holds a hearing on what can be done to curb hospital infections
A final rule from CMS makes no requirements for a pharmacist to be part of the dialysis team, creating concern among hospital pharmacists.
GSK and Aldolor's alvimopan is approved to improve GI recovery following surgery.
The Centers for Medicare & Medicaid Services is proposing regulations to control selling tactics used by Medicare Advantage and Part D plans to attract new customers.
A DEA final rule allows prescribers to order narcotics for up to 100 patients at one time for detoxification purposes.
CMS announed the names of the 325 winning suppliers that have signed contracts with Medicare to provide DMEPOS.
FDA will review claims data from Medicare and other sources to identify unsafe drugs and devices.
A suit has been filed to put a stop to the Medicare competitive bidding program for durable medical supplies.
AMCP has sent a letter to Senate leaders strongly objecting to Section 176 of S. 3101.
Eight community pharmacies have filed suit to stop Medi-Cal reimbursement cutbacks from taking effect on July 1.
To better ward off blows by the FDA to compounding pharmacists, IACP has established a satellite office at NCPA's headquarters.
Some pharmacists think CDC is doing a good job selecting the right strain for the flu vaccine, others don't think so.
